位置:首页 > 蛋白库 > PAKA_DICDI
PAKA_DICDI
ID   PAKA_DICDI              Reviewed;        1197 AA.
AC   Q55D99; Q23866; Q9XYY3;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 1.
DT   03-AUG-2022, entry version 122.
DE   RecName: Full=Serine/threonine-protein kinase pakA;
DE            Short=dPAKa;
DE            EC=2.7.11.1;
DE   AltName: Full=dpak1;
GN   Name=pakA; ORFNames=DDB_G0269166;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Evosea; Eumycetozoa; Dictyostelia; Dictyosteliales;
OC   Dictyosteliaceae; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=AX3-1;
RX   PubMed=10545500; DOI=10.1083/jcb.147.3.559;
RA   Chung C.Y., Firtel R.A.;
RT   "PAKa, a putative PAK family member, is required for cytokinesis and the
RT   regulation of the cytoskeleton in Dictyostelium discoideum cells during
RT   chemotaxis.";
RL   J. Cell Biol. 147:559-576(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AX3;
RA   Mueller-Taubenberger A.;
RL   Submitted (OCT-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A., Sucgang R.,
RA   Berriman M., Song J., Olsen R., Szafranski K., Xu Q., Tunggal B.,
RA   Kummerfeld S., Madera M., Konfortov B.A., Rivero F., Bankier A.T.,
RA   Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P., Pilcher K., Chen G.,
RA   Saunders D., Sodergren E.J., Davis P., Kerhornou A., Nie X., Hall N.,
RA   Anjard C., Hemphill L., Bason N., Farbrother P., Desany B., Just E.,
RA   Morio T., Rost R., Churcher C.M., Cooper J., Haydock S., van Driessche N.,
RA   Cronin A., Goodhead I., Muzny D.M., Mourier T., Pain A., Lu M., Harper D.,
RA   Lindsay R., Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C., Quail M.A.,
RA   Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D., Sanders M.,
RA   Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S., Tivey A.,
RA   Sugano S., White B., Walker D., Woodward J.R., Winckler T., Tanaka Y.,
RA   Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A., Cox E.C.,
RA   Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M., Kay R.R.,
RA   Williams J.G., Dear P.H., Noegel A.A., Barrell B.G., Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [4]
RP   FUNCTION, MUTAGENESIS OF THR-585, AND PHOSPHORYLATION AT THR-585.
RX   PubMed=11389841; DOI=10.1016/s1097-2765(01)00247-7;
RA   Chung C.Y., Potikyan G., Firtel R.A.;
RT   "Control of cell polarity and chemotaxis by Akt/PKB and PI3 kinase through
RT   the regulation of PAKa.";
RL   Mol. Cell 7:937-947(2001).
CC   -!- FUNCTION: Regulator of the myosin II component of the cytoskeleton:
CC       required for regulation of cytokinesis. Functions during chemotaxis,
CC       required for maintaining the direction of cell movement, suppressing
CC       lateral pseudopod extension, and proper retraction of the posterior of
CC       chemotaxing cells. {ECO:0000269|PubMed:10545500,
CC       ECO:0000269|PubMed:11389841}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:10545500}.
CC       Cytoplasm, cytoskeleton {ECO:0000269|PubMed:10545500}. Note=Cytosolic
CC       in unstimulated cells, localizes to the cytoskeleton in response to
CC       chemoattractant stimulation.
CC   -!- TISSUE SPECIFICITY: Colocalizes with myosin II to the cleavage furrow
CC       of cells undergoing cytokinesis and the posterior cortex of polarized
CC       cells. {ECO:0000269|PubMed:10545500}.
CC   -!- PTM: Phosphorylation on Thr-585 results in cAMP-mediated activation and
CC       localization to the cytoskeleton. {ECO:0000269|PubMed:11389841}.
CC   -!- DISRUPTION PHENOTYPE: cells exhibit a defect in completing cytokinesis
CC       when grown in suspension, suggesting difficulties in regulating
CC       cytoskeletal organization required for cytokinesis, although
CC       karyokinesis is normal. {ECO:0000269|PubMed:10545500}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF131221; AAD28470.1; -; mRNA.
DR   EMBL; U51923; AAA93038.2; -; mRNA.
DR   EMBL; AAFI02000005; EAL71933.1; -; Genomic_DNA.
DR   RefSeq; XP_646232.1; XM_641140.1.
DR   AlphaFoldDB; Q55D99; -.
DR   SMR; Q55D99; -.
DR   BioGRID; 1242191; 1.
DR   STRING; 44689.DDB0191313; -.
DR   iPTMnet; Q55D99; -.
DR   PaxDb; Q55D99; -.
DR   EnsemblProtists; EAL71933; EAL71933; DDB_G0269166.
DR   GeneID; 8617188; -.
DR   KEGG; ddi:DDB_G0269166; -.
DR   dictyBase; DDB_G0269166; pakA.
DR   eggNOG; KOG0578; Eukaryota.
DR   HOGENOM; CLU_271206_0_0_1; -.
DR   InParanoid; Q55D99; -.
DR   OMA; SWADRRE; -.
DR   Reactome; R-DDI-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-DDI-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-DDI-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-DDI-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-DDI-9013149; RAC1 GTPase cycle.
DR   Reactome; R-DDI-9013404; RAC2 GTPase cycle.
DR   Reactome; R-DDI-9013406; RHOQ GTPase cycle.
DR   Reactome; R-DDI-9013407; RHOH GTPase cycle.
DR   Reactome; R-DDI-9013420; RHOU GTPase cycle.
DR   Reactome; R-DDI-9013423; RAC3 GTPase cycle.
DR   Reactome; R-DDI-9013424; RHOV GTPase cycle.
DR   PRO; PR:Q55D99; -.
DR   Proteomes; UP000002195; Chromosome 1.
DR   GO; GO:0005938; C:cell cortex; IDA:dictyBase.
DR   GO; GO:0031254; C:cell trailing edge; IDA:dictyBase.
DR   GO; GO:0032154; C:cleavage furrow; IDA:dictyBase.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0097204; C:phagocytic cup base; IDA:dictyBase.
DR   GO; GO:0001931; C:uropod; IDA:dictyBase.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0045159; F:myosin II binding; IMP:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0031152; P:aggregation involved in sorocarp development; IMP:dictyBase.
DR   GO; GO:0048870; P:cell motility; IMP:dictyBase.
DR   GO; GO:0006935; P:chemotaxis; IMP:dictyBase.
DR   GO; GO:0043327; P:chemotaxis to cAMP; IMP:UniProtKB.
DR   GO; GO:0030010; P:establishment of cell polarity; IGI:dictyBase.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; TAS:dictyBase.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0000281; P:mitotic cytokinesis; IMP:dictyBase.
DR   GO; GO:0031036; P:myosin II filament assembly; IMP:dictyBase.
DR   GO; GO:0006909; P:phagocytosis; IMP:dictyBase.
DR   GO; GO:0032467; P:positive regulation of cytokinesis; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   GO; GO:0031156; P:regulation of sorocarp development; IMP:dictyBase.
DR   GO; GO:1903013; P:response to differentiation-inducing factor 1; HDA:dictyBase.
DR   CDD; cd01093; CRIB_PAK_like; 1.
DR   Gene3D; 3.90.810.10; -; 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR036936; CRIB_dom_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR033923; PAK_BD.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chemotaxis; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..1197
FT                   /note="Serine/threonine-protein kinase pakA"
FT                   /id="PRO_0000327474"
FT   DOMAIN          817..830
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   DOMAIN          911..1164
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..96
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          328..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          430..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          485..543
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          562..819
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        30..50
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..69
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        70..95
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        341..383
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        495..543
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        588..616
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        634..726
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        740..755
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        756..792
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        1032
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         917..925
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         940
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         585
FT                   /note="Phosphothreonine; by PKB"
FT                   /evidence="ECO:0000269|PubMed:11389841"
FT   MUTAGEN         585
FT                   /note="T->A: Loss of phosphorylation in response to cAMP."
FT                   /evidence="ECO:0000269|PubMed:11389841"
FT   MUTAGEN         585
FT                   /note="T->D: Constitutively active."
FT                   /evidence="ECO:0000269|PubMed:11389841"
FT   CONFLICT        30
FT                   /note="K -> R (in Ref. 1; AAD28470 and 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        48..53
FT                   /note="Missing (in Ref. 1; AAD28470)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="Q -> H (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240
FT                   /note="E -> D (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        379..380
FT                   /note="NK -> F (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        392
FT                   /note="N -> Y (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        466..467
FT                   /note="QR -> LL (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        659
FT                   /note="H -> L (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1081
FT                   /note="G -> S (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1085
FT                   /note="D -> N (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1113
FT                   /note="L -> H (in Ref. 2; AAA93038)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1197 AA;  134650 MW;  3B76B9D3F073F51E CRC64;
     MEEKPKSTTP PPSVSSLRQK FEQFLDKTDK GFNATRNNYR GPVSSSTGII NDKEKKSHSY
     FKVREEGSNK RPSSFSASNP ITPSSPQSTH SSPIYRGVGY HQYSSVNSGN SYSGSGNNIN
     NIINNSNNSN SNNLYGNNSN NQSSGSLGNF LIDKLEYSAA TVTASDLKRE RQQLFRNKEE
     FTMESSSYGG STIGDDDLDS LNGSSSQQFN HRNSSWADRR ERFIKKVMNG QFNEVQMRDE
     LNRLRDIEAD KIRAEERRTP SMNMDEFKAI EIERLRKKIY QEELVIFRQE EIEKIQREER
     IKIEKEYDDK SIISSQERQH IVQQIINQKE DEKGSSPPFP IPLVVNNNNN ENNENDNNNN
     NNNNNNNNNN NNNNNNNNNK NIDLTSFNNN ININSNNNEI KNNVIVDSDD EEELERLEQL
     RRQREIERLR EEEEENEDRV ERELASRRRQ EEDRIKREEE EEEEEQRNYL RRLKELERIK
     QIEEEEEEER ERQSQLQSSQ QQQKSSSTQR SSNTVTSTSS SSTGGDSNPS TSQKPTNLLN
     LMGSNNNISN INTNILSHSI VNSSGGLPPP PPTASHVDNR SRSHTLAGES HSSENTPLVS
     SIDNNGVNNK MSRSHSGGAL SGLALPTAPP LPNQPNVNNS NNNNNNNNIN NNHNHSHNHS
     NNLHQSALKN SSSMSTPSIS PSQAGNSATS TVPSSPISAS TSMSSPTLVV SPRKDELTTS
     TGSTRKGSIS EREDKKKVSS SSTSSSSSSN GGLSSSGKDH KKDHSSEEKE KEKKSFFNKL
     FSKEKKDHHS SSKSPSSGSS GGGEVDEKKK KKLSPRVGTP FNVKHDVHVN FNADTGFEGL
     PKEWEVLIKS NFQEPEVMQH PEEVLDVVKF HAQYQGLASA PAMHAPSIPL TDEPPVTLND
     LISLDDPKKI YYNINKIGEG GAGEVFEAIN SRTNQTIAIK KMKLKAQNLK TVINEIGMMK
     NSNHENIVQY IDSYIVADEL WVAMEFMSGG CLTEVLDQYR DIQLNESQIA FVCQEVLRGL
     EYIHKFNRIH RDIKSDNILI GANGEIKLAD FGYAAQLTQI RQERNSVVGT PYWMAPELIR
     GNNYDFKVDV WSLGIMTREM AEGEPPYLEF PPLRALFLLT TQGLPPIRDA HKWSKEFNDF
     LALCLEKDTE KRASSSSLLH HPFLKRACSG PEFYKAVDAA RIEKENQLQN FANLTAI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024